UPDATE: JMP Securities Initiates Coverage On Pernix Therapeutics On Positive Growth Outlook
Salix Pharmaceutical's Inversion Deal Makes It Unlikely Merger Target, Dilutes EPS
UPDATE: Jefferies Reiterates on Actavis PLC Following In-Line Q3 Results, Solid '14 Guidance
UPDATE: Jefferies Raises PT on AcelRx Pharmaceuticals on Numerous Potential Catalysts Ahead